Why the study?
Does cardiac pacing prevent syncope or improve symptoms in patients with vasovagal syncope?
Does cardiac pacing prevent syncope or improve symptoms in patients with vasovagal syncope?
While cardiac pacing does not prevent the onset of tilt-induced vasovagal syncope, it may prolong the presyncopal period and improve symptoms in patients with a prominent cardioinhibitory component.
Answers are grounded in this paper and cite their sources.
Does not support pacing to prevent tilt-induced vasovagal syncope; leaves open symptom palliation in cardioinhibitory cases pending randomized data.
A number of studies have evaluated the effect of cardiac pacing for prevention of tilt induced vasovagal syncope. The findings are relatively consistent. Pacing does not prevent the onset of vasovagal syncope. This is predictable since hypotension (vasodepressor effect) typically occurs prior to bradycardia. However, dual chamber may prolong the presyncopal period in patients with a prominent cardioinhibitory component. Further, the relation of laboratory observations to spontaneous events is uncertain. In the largest retrospective assessment of pacing efficacy, 89% of patients reported improved symptoms and 62% remained free of symptom recurrence over 50 months.
No takes yet. Share an insight, caveat, or question.
PETERSEN et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: